Key Takeaways
- • California legislators are advancing the Private Equity Sunshine Act (SB 1319), which would amend the California Public Records Act to require state pension systems to disclose alternative-investment returns and benchmark them against public stock indexes.
- • The legislation represents a significant transparency push targeting private equity and alternative investment performance within California's public pension system, a critical test case for institutional investor oversight at the state level.
- • Multiple related bills are advancing through the California legislature, including measures to restrict private equity influence in law firms, health care acquisitions, and website-based liability — signaling a broader legislative effort to constrain private fund industry control across sectors.
- • State attorneys general are gaining new enforcement powers under proposed legislation, including requirements for prior AG approval on certain private equity transactions, reflecting growing regulatory scrutiny of the sector.
- • The advancement of these bills through California's legislative process signals that major state pension systems may soon face mandatory disclosure requirements that could reshape how alternative investments are evaluated and reported to beneficiaries.
Summary
The legislation addresses long-standing concerns from pension beneficiaries and oversight advocates regarding the opacity of private equity and hedge fund performance within public pension portfolios. By requiring comparative benchmarking against public equities, the bill would enable stakeholders to assess whether alternative investments justify their substantially higher fees and illiquidity relative to traditional index-based approaches. The disclosure requirements are expected to generate comment from private fund industry groups as the bill continues through the legislative process.
Beyond SB 1319, California lawmakers are advancing a coordinated legislative agenda targeting private equity influence across multiple sectors. Related bills include measures prohibiting private equity firms, hedge funds, and corporate investors from directing or controlling law firm operations; restricting private equity and hedge fund acquisitions in health care delivery systems; and requiring state attorney general approval for certain private equity transactions. These parallel efforts underscore growing legislative concern about concentrated private fund control and suggest that California—home to some of the nation's largest institutional investors—is positioning itself as a regulatory leader in private equity oversight.
The California Senate has already passed legislation designed to constrain health care acquisitions by private equity firms and hedge funds, reflecting a broader nationwide trend of states seeking new regulatory powers to govern private fund industry conduct. Industry observers anticipate these bills will face significant opposition from large private equity sponsors, including top-tier firms that have substantially increased their deployment of capital in recent years. The outcome of California's legislative efforts will likely influence regulatory approaches in other major states and potentially signal investor appetite for mandatory alternative investment transparency at the federal level.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.